|
|
|
|
|
|
|
|
|
|
|
| Experimental Information | |
| Enzymatic Activity | |
| Molecule Id | EGIN0005038 |
| PMID | 23900004 |
| Assay Used | Kinase assays |
| Experimently Validated | Yes |
| EGFR (IC50) | - |
| HER2 (IC50) | - |
| HER4 (IC50) | - |
| Mutant L858R (IC50) | - |
| Mutant T790M (IC50) | - |
| Double Mutant (IC50) | - |
| Average ERBB2 and ERBB1 (IC50) | - |
| Inhibition EGFR (%) | 20% |
| Inhibitory Concentration | - |
| Inhibition HER2 (%) | - |
| Inhibitory Concentration | - |
| Ki (EGFR) | - |
| Ki (HER2) | - |
| Ki (HER4) | - |
| Kd (EGFR) | - |
| Kd (L858R) | - |
| Kd (T790M) | - |
| Kd (L858R/T790M) | - |
| Kd (Other mutation) | - |
| Note | - |
| Extra | - |
| Cellular Activity | ||||||||||||||
| S.No. | Cell Line | Desp. | IC50 | IC80 | ED50 | GI50 | GI90 | EC50 | Kd | Inhibition (%) | Inhibitory Conc. | |||
| 1 | A431 | A431 human vulvar squamous carcinoma cells overexpressing HER-1 | 80±10 nM | - | - | - | - | - | - | - | - | |||
| 2 | NIH3T3 | NIH3T3 murine embryonic fibroblast-like cells lacking EGF receptors | 600±200 nM | - | - | - | - | - | - | - | - | |||
| 3 | MCF-7b | breast carcinoma cell line | 740±60 nM | - | - | - | - | - | - | - | - | |||
| 4 | HT29 | human colonic adenocarcinoma | 680±360 nM | - | - | - | - | - | - | - | - | |||
| 5 | HeLa | cervical cancer | 620±10 nM | - | - | - | - | - | - | - | - | |||
| 6 | BNL | murine hepatocellular carcinoma cell line | 2700±350 nM | - | - | - | - | - | - | - | - | |||
| 7 | HUVEC | human umbilical vein cord cells | 80±10 nM | - | - | - | - | - | - | - | - | |||
| Activity against Receptor | |
| EGFR | Yes |
| HER2 | - |
| HER4 | - |
| Wild type | Yes |
| Mutant | - |
| Inhibitor Binding | |
| EGFR | - |
| HER2 | - |
| HER4 | - |